Publications

Sane RS, Steinmann GG, Huang Q, Li Y, Podila L, Mease K, Olson S, Taub ME, et al. 2014. Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in HCV patients. J Pharmacol Exp Ther 351(2):403–412; doi: 10.1124/jpet.114.218081. PMID: 25204339.

Proctor DM, Suh M, Campleman SL, Thompson CM. 2014. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Toxicol 325(Nov):160-179; doi: 10.1016/j.tox.2014.08.009.

Johnson GE, Soeteman-Hernandez, Gollapudi BB, Bodger OG, Dearfield KL, RH Heflich, Hixon JG, Lovell DP, MacGregor JT, Pottenger LH, Thompson CM, Abraham L, Thybaud V, Tanir JY, Zeiger E, van Benthem J, White PA. 2014. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Molec Mutagen 55(8):609-623; doi: 10.1002/em.21870/em.21870.

Wirbisky SE, Weber GJ, Lee JW, Cannon JR, Freeman JL. 2014. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity. Toxicol Lett 229:1–8.

Henderson R, Verougstraete V, Anderson K, Arbildua JJ, Brock TO, Brouwers T, Cappellini D, Delbeke K, Herting G, Hixon G, Wallinder IO, Rodriguez PH, Assche FV, Wilrich P, Oller AR. 2014. Interlaboratory validation of bioaccessibility testing for metals. Regul Toxicol Pharmacol 70(1):170-181. doi: 10.1016/j.yrtph.2014.06.02.

Wheeler MW, Dunson DB, Pandalai SP, Baker BA, Herring AH. 2014. Mechanistic hierarchical Gaussian processes. J Amer Stat Assoc 109(507):894-904; doi: 10.1080/01621459.2014.899234. PMCID: PMC4273873.

Faber W, Kirkpatrick D, Coder P, Li P, Borghoff S, Banton M. 2014. Subchronic, reproductive, and maternal toxicity studies with tertiary butyl acetate (TBAC). Regul Toxicol Pharmacol 68:332-342.

Christian WV, Oliver LD, Paustenbach DJ, Kreider ML, Finley BL. 2014. Toxicology-based cancer causation analysis of CoCr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies. J Appl Toxicol 34(9):939–967.

Paustenbach D, Galbraith D, Finley B. 2014. Letter to the Editor: Authors’ response to letters to the editor re: Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(5):569–570.

Finley BL, Scott PK. 2014. Diacetyl and “popcorn lung” litigation: Assessing the evidence for general causation. ABA Environ Litigation Toxic Torts Newsletter 15(2):7–10.

Kerger BD, Thuett KA, Finley BL. 2014. Evaluation of four a-diketones for toll-like receptor-4 (TLR-4) activation in a human transfected cell line. Food Chem Toxicol 74:117–119.

Dingley KH, Ubick EA, Vogel JS, Ognibene TJ, Malfatti MA, Kulp K, Haack KW. 2014. DNA isolation and sample preparation for quantification of adduct levels by accelerator mass spectrometry. Methods Mol Biol 1105:147–157; doi: 10.1007/978-1-62703-739-6_12. PMID: 24623226.

Moyes CR, Berger R, Goble SD, Harper B, Shen DM, Wang L, … Dingley KH, et al. 2014. Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladder. J Med Chem 57(4):1437–1453; doi: 10.1021/jm4017224. PMID: 24437735.

Paustenbach DJ, Galbraith DA, Finley BL. 2014. Interpreting cobalt blood concentrations in hip implant patients. Clin Toxicol 52(2):98–112; doi: 10.3109/15563650.2013.857024. PMID: 24256093.

Pierce JS, Abelmann A, SpicerLJ, Adams RE, Finley BL. 2014. Diacetyl and 2,3-pentanedione exposures associated with cigarette smoking: Implications for risk assessment of food and flavoring workers. Crit Rev Toxicol 44(5):420–435; doi: 10.3109/10408444.2014.882292. PMID: 24635357.

Unice KM, Kerger BD, Paustenbach DJ, Finley BL, Tvermoes BE. 2014. Refined biokinetic model for humans exposed to cobalt dietary supplements and other sources of systemic cobalt exposure. Chem-Biol Interact 216:53–74; doi: 10.1016/j.cbi.2014.04.001. PMID: 24726710.

Monnot AD, Christian WV, Paustenbach DJ, Finley BL. 2014. Correlation of blood Cr(III) and adverse health effects: Application of PBPK modeling to determine non-toxic blood concentrations. Crit Rev Toxicol 44(7):618–637; doi:10.3109/10408444.2014.926472. PMID: 25068491.

Tvermoes BE, Unice KM, Paustenbach DJ, Finley BL, Otani JM, Galbraith DA. 2014. Effects and blood concentrations of cobalt after ingestion of 1 mg/d by human volunteers for 90 d1-3. Am J Clin Nutr 99(3):632–646; doi: 10.3945/ajcn.113.071449. PMID: 24500148.

Beasley TE, Evansky PA, Martin SA, McDaniel KL, Moser VC, Luebke RW, Norwood J Jr, Rogers JM, Copeland C, Bushnell PJ. 2014. Toxicological outcomes in rats exposed to inhaled ethanol during gestation. Neurotoxicol Teratol 45(Sept-Oct):59–69; doi: 10.1016/j.ntt.2014.07.002.

Daston GP, Beyer BK, Carney EW, Chapin RE, Friedman JM, Piersma AH, Rogers JM, Scialli AR. 2014. Exposure-based validation list for developmental toxicity screening assays. Birth Defects Res B 101(6):423–428; doi: 10.1002/bdrb.21132.